Join The Registry
By sharing your information, you help us continue to grow the largest global GABAAR (GABA-A Receptor) patient community, strengthen natural history data, and accelerate the development of real treatments. What began with one little girl’s journey has grown into a global effort to move science forward for all families affected by GABAAR variants.
Major Milestone: Partnership for mRNA Therapy Proof-of-Concept.
“In a historic milestone for genetic medicine, the first-ever mRNA therapy was successfully administered to a patient, marking a new era for disorders like GABAARs.” Press Release
In August 2025, CURE GABA-A reached a historic milestone by announcing a major new partnership with Grann Pharmaceuticals to develop nanolipid particle (LNP) protein replacement therapies. This collaboration follows the successful completion of the initial safety regimen for RTT-1 (ELEANOR), marking a critical step forward for rare neurodevelopmental disorders. Press Release
Key Achievements:
-
Strategic Partnership: Formalized agreement to lead preclinical animal studies targeting GABAAR variants (specifically GABRA1 and GABRG2).
-
mRNA Innovation: Utilizing an innovative therapeutic platform to restore healthy GABA-A receptor function.
-
Global Network: This milestone connects our patient community directly with industry experts to move from “drug-in-a-fridge” to real-world clinical readiness.
This breakthrough represents our commitment to turning research into treatment and bringing hope to every family in our global registry.
Your Information Here
Why Parents Choose to Share Their Data
If you’re here, it’s because you’re searching for answers, options, and hope. We understand that sharing your child’s information is a big decision.
1️⃣ How your child’s data helps create treatments
Without patient data, therapies cannot move forward.
Your child’s information helps us:
-
Build the natural history required for clinical trials
-
Show researchers and industry that this community is real and ready
-
Accelerate the development of targeted therapies
This is how we move from waiting to action.
2️⃣ This work is already happening
We are not starting from zero.
-
The first mRNA therapy has already been given
-
Active mouse studies are underway right now
-
Clinical readiness is being built in real time
Your participation connects directly to real progress.
3️⃣ You are not alone
Rare disease can feel isolating. It doesn’t have to be.
By joining, you become part of:
-
The largest global GABA-A community
-
A network of families, clinicians, and researchers
-
A movement built by parents, for parents
4️⃣ What this could mean for your child
Participation may help:
-
Identify opportunities for future studies or trials
-
Connect you to emerging research
-
Keep you informed as treatments develop
5️⃣ Your privacy and control
We take your trust seriously.
-
Your data is used to advance research and clinical readiness
- All personal and medical information is kept strictly confidential, with privacy controls in place to limit access to authorized individuals only.
6️⃣ Why this matters
Every family who shares their story strengthens the science.
What began as a fight for one child has become a pathway for many.
Your child’s data has the power to shape the future of treatment. Your voice and participation are important. Your story is important and your data is important. Please share it.

